Viewing Study NCT05257395


Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2025-12-31 @ 5:50 AM
Study NCT ID: NCT05257395
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-17
First Post: 2022-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-03-14
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-05
Primary Completion Date Type: ESTIMATED
Completion Date: 2030-09-05
Completion Date Type: ESTIMATED
First Submit Date: 2022-02-16
First Submit QC Date: None
Study First Post Date: 2022-02-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-14
Last Update Post Date: 2025-07-17
Last Update Post Date Type: ACTUAL